This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2je5
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 2je5 |SIZE=350|CAPTION= <scene name='initialview01'>2je5</scene>, resolution 2.60Å | |PDB= 2je5 |SIZE=350|CAPTION= <scene name='initialview01'>2je5</scene>, resolution 2.60Å | ||
|SITE= <scene name='pdbsite=AC1:L4c+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:L4c+Binding+Site+For+Chain+B'>AC2</scene>, <scene name='pdbsite=AC3:So4+Binding+Site+For+Chain+B'>AC3</scene>, <scene name='pdbsite=AC4:So4+Binding+Site+For+Chain+A'>AC4</scene>, <scene name='pdbsite=AC5:Cl+Binding+Site+For+Chain+A'>AC5</scene>, <scene name='pdbsite=AC6:Cl+Binding+Site+For+Chain+A'>AC6</scene>, <scene name='pdbsite=AC7:Cl+Binding+Site+For+Chain+B'>AC7</scene> and <scene name='pdbsite=AC8:Cl+Binding+Site+For+Chain+B'>AC8</scene> | |SITE= <scene name='pdbsite=AC1:L4c+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:L4c+Binding+Site+For+Chain+B'>AC2</scene>, <scene name='pdbsite=AC3:So4+Binding+Site+For+Chain+B'>AC3</scene>, <scene name='pdbsite=AC4:So4+Binding+Site+For+Chain+A'>AC4</scene>, <scene name='pdbsite=AC5:Cl+Binding+Site+For+Chain+A'>AC5</scene>, <scene name='pdbsite=AC6:Cl+Binding+Site+For+Chain+A'>AC6</scene>, <scene name='pdbsite=AC7:Cl+Binding+Site+For+Chain+B'>AC7</scene> and <scene name='pdbsite=AC8:Cl+Binding+Site+For+Chain+B'>AC8</scene> | ||
| - | |LIGAND= | + | |LIGAND= <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=L4C:(2E)-2-{[(2S)-2-(ACETYLAMINO)-2-CARBOXYETHOXY]IMINO}PENTANEDIOIC+ACID'>L4C</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> |
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY=[[2bg1|2BG1]], [[2bg3|2BG3]], [[2bg4|2BG4]], [[2fff|2FFF]], [[2jch|2JCH]], [[2jci|2JCI]] | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2je5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2je5 OCA], [http://www.ebi.ac.uk/pdbsum/2je5 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2je5 RCSB]</span> | ||
}} | }} | ||
| Line 30: | Line 33: | ||
[[Category: Schofield, C J.]] | [[Category: Schofield, C J.]] | ||
[[Category: Zervosen, A.]] | [[Category: Zervosen, A.]] | ||
| - | [[Category: CL]] | ||
| - | [[Category: L4C]] | ||
| - | [[Category: SO4]] | ||
[[Category: cell wall]] | [[Category: cell wall]] | ||
[[Category: drug-binding protein]] | [[Category: drug-binding protein]] | ||
| Line 39: | Line 39: | ||
[[Category: peptidoglycan synthesis multifunctional enzyme]] | [[Category: peptidoglycan synthesis multifunctional enzyme]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 03:56:53 2008'' |
Revision as of 00:56, 31 March 2008
| |||||||
| , resolution 2.60Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | , , , , , , and | ||||||
| Ligands: | , , | ||||||
| Related: | 2BG1, 2BG3, 2BG4, 2FFF, 2JCH, 2JCI
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
STRUCTURAL AND MECHANISTIC BASIS OF PENICILLIN BINDING PROTEIN INHIBITION BY LACTIVICINS
Overview
Beta-lactam antibiotics, including penicillins and cephalosporins, inhibit penicillin-binding proteins (PBPs), which are essential for bacterial cell wall biogenesis. Pathogenic bacteria have evolved efficient antibiotic resistance mechanisms that, in Gram-positive bacteria, include mutations to PBPs that enable them to avoid beta-lactam inhibition. Lactivicin (LTV; 1) contains separate cycloserine and gamma-lactone rings and is the only known natural PBP inhibitor that does not contain a beta-lactam. Here we show that LTV and a more potent analog, phenoxyacetyl-LTV (PLTV; 2), are active against clinically isolated, penicillin-resistant Streptococcus pneumoniae strains. Crystallographic analyses of S. pneumoniae PBP1b reveal that LTV and PLTV inhibition involves opening of both monocyclic cycloserine and gamma-lactone rings. In PBP1b complexes, the ring-derived atoms from LTV and PLTV show a notable structural convergence with those derived from a complexed cephalosporin (cefotaxime; 3). The structures imply that derivatives of LTV will be useful in the search for new antibiotics with activity against beta-lactam-resistant bacteria.
About this Structure
2JE5 is a Single protein structure of sequence from Streptococcus pneumoniae. Full crystallographic information is available from OCA.
Reference
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins., Macheboeuf P, Fischer DS, Brown T Jr, Zervosen A, Luxen A, Joris B, Dessen A, Schofield CJ, Nat Chem Biol. 2007 Sep;3(9):565-9. Epub 2007 Aug 5. PMID:17676039
Page seeded by OCA on Mon Mar 31 03:56:53 2008
